London-based Synthace Ltd, a cloud-based platform that helps improve the success rate of biological research, has closed a $25.6-million Series B financing round led by Hong Kong-based Horizons Ventures, the private investment arm of investor Li Ka-shing, according to an announcement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in